Pneumocystis prophylaxis needed when CD 24 count is?
**Core Concept**
Pneumocystis jirovecii pneumonia (PCP) is a life-threatening opportunistic infection that affects immunocompromised individuals, particularly those with HIV/AIDS. The risk of developing PCP increases with a lower CD4 count, which indicates a weakened immune system.
**Why the Correct Answer is Right**
The correct answer is associated with the initiation of prophylactic therapy to prevent PCP. When the CD4 count falls below 200 cells/mm^3, the risk of PCP increases significantly, and prophylaxis is recommended to prevent this opportunistic infection. The most commonly used agents for PCP prophylaxis are trimethoprim-sulfamethoxazole (TMP-SMX), atovaquone, and dapsone.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is too high; a CD4 count above 200 cells/mm^3 is not typically associated with a need for PCP prophylaxis.
**Option B:** This option is incorrect because it is too low; a CD4 count below 100 cells/mm^3 would be more indicative of a need for PCP prophylaxis.
**Option C:** This option is incorrect because it is not a specific CD4 count threshold; prophylaxis is typically recommended when the CD4 count falls below a certain threshold, not when it is above a certain threshold.
**Clinical Pearl / High-Yield Fact**
The Centers for Disease Control and Prevention (CDC) recommend that individuals with HIV/AIDS initiate PCP prophylaxis when their CD4 count falls below 200 cells/mm^3. However, some experts recommend starting prophylaxis when the CD4 count falls below 150 cells/mm^3.
**Correct Answer:** C. 150-200, though typically 200.